wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q49097109-2E8C144D-B4E4-45F2-80B5-8993835CCF83
Q49097109-2E8C144D-B4E4-45F2-80B5-8993835CCF83
BestRank
Statement
http://www.wikidata.org/entity/statement/Q49097109-2E8C144D-B4E4-45F2-80B5-8993835CCF83
Neither creatinine nor cystatin C-estimated glomerular filtration rate is optimal in oncology patients treated with targeted agents.
P2860
Q49097109-2E8C144D-B4E4-45F2-80B5-8993835CCF83
BestRank
Statement
http://www.wikidata.org/entity/statement/Q49097109-2E8C144D-B4E4-45F2-80B5-8993835CCF83
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ae5620d12df11fcf479d9e71bb726bc6cbea6e77
P2860
A randomised, double-blind phase III study of pazopanib in patients with advanced and/or metastatic renal cell carcinoma: final overall survival results and safety update.